Key result
Noninvasive pulse wave velocity spans four modalities but faces three major barriers to clinical translation.
Why the study?
Despite the clinical value of pulse wave velocity as an independent predictor of cardiovascular risk, its accurate and reliable measurement remains methodologically challenging due to physical ambiguities, technological heterogeneity across devices, and a lack of comparability between different systems.
Synthesizes the physical foundations, four primary technological modalities, and key clinical translation barriers of noninvasive pulse wave velocity measurement for assessing arterial stiffness and cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Translation barriers limit noninvasive PWV integration; leaves open needs for automated, validated, prognostic multicenter studies.
Pulse wave velocity (PWV) is increasingly recognized as a vital noninvasive metric for assessing arterial stiffness and an established independent predictor of cardiovascular risk. Despite its well-recognized clinical value, the accurate and reliable measurement of PWV remains methodologically challenging due to inherent physical ambiguities, technological heterogeneity across devices, and a lack of comparability between measurements obtained by different systems. This review provides a comprehensive synthesis of the physical foundations, mainstream detection technologies, signal-processing pipelines, and current clinical standardization status for PWV assessment. Although classical frameworks such as the Moens-Korteweg and Bramwell-Hill equations theoretically link PWV to the mechanical properties of the arterial wall, the intrinsic dependence of PWV on instantaneous blood pressure complicates the precise evaluation of structural arterial stiffness in clinical settings. We categorize existing measurement modalities into four principal types: mechanical-pressure sensing, optical techniques, advanced medical imaging, and emerging contactless approaches, each demonstrating unique trade-offs among measurement fidelity, clinical applicability, and operational convenience. Presently, three major barriers hinder the clinical translation of novel technologies: insufficient operational automation, inadequate cross-population validation, and a scarcity of longitudinal prognostic evidence. Future transformative advancements will likely rely on AI-driven, fully automated continuous monitoring systems optimized for real-world daily settings, large-scale multicenter trials across diverse demographics, and extensive long-term cohort studies utilizing wearable devices. These developments will collectively extend PWV assessment from intermittent clinical evaluation toward decentralized, personalized cardiovascular risk management.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a review in Arterial stiffness and cardiovascular risk. Noninvasive pulse wave velocity (PWV) measurement was evaluated. Noninvasive pulse wave velocity measurement spans 4 modalities (mechanical, optical, imaging, contactless) and faces 3 major translation barriers.
Synapse has enriched 10 related papers. Consider them for comparative context: